PRN Medicines Optimization and Nurse Education

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10045/110008
Información del item - Informació de l'item - Item information
Título: PRN Medicines Optimization and Nurse Education
Autor/es: Vaismoradi, Mojtaba | Jordan, Sue | Vizcaya-Moreno, M. Flores | Friedl, Ingrid | Glarcher, Manela
Grupo/s de investigación o GITE: Enfermería Clínica (EC)
Centro, Departamento o Servicio: Universidad de Alicante. Departamento de Enfermería
Palabras clave: Education | Medicines management | Nurse | Patient safety | Pro re nata | PRN
Área/s de conocimiento: Enfermería
Fecha de publicación: 26-oct-2020
Editor: MDPI
Cita bibliográfica: Vaismoradi M, Jordan S, Vizcaya-Moreno F, Friedl I, Glarcher M. PRN Medicines Optimization and Nurse Education. Pharmacy. 2020; 8(4):201. https://doi.org/10.3390/pharmacy8040201
Resumen: Medicines management is a high-risk and error prone process in healthcare settings, where nurses play an important role to preserve patient safety. In order to create a safe healthcare environment, nurses should recognize challenges that they face in this process, understand factors leading to medication errors, identify errors and systematically address them to prevent their future occurrence. ‘’Pro re nata’’ (PRN, as needed) medicine administration is a relatively neglected area of medicines management in nursing practice, yet has a high potential for medication errors. Currently, the international literature indicates a lack of knowledge of both the competencies required for PRN medicines management and the optimum educational strategies to prepare students for PRN medicines management. To address this deficiency in the literature, the authors have presented a discussion on nurses’ roles in medication safety and the significance and purpose of PRN medications, and suggest a model for preparing nursing students in safe PRN medicines management. The discussion takes into account patient participation and nurse competencies required to safeguard PRN medication practice, providing a background for further research on how to improve the safety of PRN medicines management in clinical practice.
URI: http://hdl.handle.net/10045/110008
ISSN: 2226-4787
DOI: 10.3390/pharmacy8040201
Idioma: eng
Tipo: info:eu-repo/semantics/article
Derechos: © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Revisión científica: si
Versión del editor: https://doi.org/10.3390/pharmacy8040201
Aparece en las colecciones:INV - Enfermería Clínica - Artículos de Revistas

Archivos en este ítem:
Archivos en este ítem:
Archivo Descripción TamañoFormato 
ThumbnailVaismoradi_etal_2020_Pharmacy.pdf455,34 kBAdobe PDFAbrir Vista previa


Este ítem está licenciado bajo Licencia Creative Commons Creative Commons